Should You Get a Calcium Score? A Menopause Heart Health Guide

Why Menopause Changes the Heart Disease Equation

Cardiovascular disease kills more women than all cancers combined, and the menopausal transition is the inflection point. Before menopause, endogenous estradiol supports endothelial function, favorable lipid profiles, and lower arterial stiffness. Once estrogen production drops, LDL cholesterol rises, HDL particle quality shifts, and coronary plaque accrual accelerates.

The Estrogen Gap

Data from the Multi-Ethnic Study of Atherosclerosis (MESA, N=6,814) showed that women who entered menopause before age 46 had significantly higher CAC progression rates than women who transitioned later [1]. A 2020 analysis in the Journal of the American Heart Association found that each year of earlier menopause was associated with a 4% increase in CAC incidence over a 15-year follow-up [2]. Surgical menopause (bilateral oophorectomy) carried an even steeper slope.

Hidden Risk in "Low-Risk" Women

Standard risk calculators like the Pooled Cohort Equations tend to underestimate risk in younger postmenopausal women because age is the dominant variable. A 52-year-old woman with mildly elevated LDL, no diabetes, and normal blood pressure may calculate at 4% 10-year risk. That number looks reassuring. A CAC scan showing a score of 85 tells a different story and would move her into a category where statin initiation is recommended per the 2019 ACC/AHA guidelines [3].

"The coronary artery calcium score is the most powerful single predictor of future cardiac events in asymptomatic adults," wrote Dr. Michael Blaha of Johns Hopkins in a 2017 review published in Progress in Cardiovascular Diseases [4].

What a CAC Score Actually Measures

A CAC scan uses a non-contrast, ECG-gated CT to detect calcium deposits in the walls of the coronary arteries. The result is an Agatston score calculated from the density and area of calcified plaques across all four major coronary vessels. No IV, no fasting, no sedation. The scan itself takes roughly 10 seconds of breath-holding.

Score Ranges and What They Mean

| Agatston Score | Plaque Burden | Clinical Implication | |---|---|---| | 0 | No detectable calcified plaque | Very low short-term risk; consider deferring statin | | 1 to 99 | Mild | Elevated above zero; lifestyle intensification, discuss statin | | 100 to 399 | Moderate | Statin therapy generally recommended | | 400+ | Extensive | High event risk; aggressive prevention warranted |

A score of 0 is clinically powerful. In MESA, participants with CAC = 0 had a 10-year coronary event rate below 2%, and this held across all racial and ethnic subgroups [5]. For a postmenopausal woman debating whether to start a statin she is reluctant to take, a zero score can justify watchful waiting with repeat assessment in 5 to 10 years.

Percentile Context Matters

Raw Agatston numbers need age- and sex-adjusted percentile context. A score of 50 in a 48-year-old woman places her above the 90th percentile for her demographic, a finding that carries very different weight than the same score in a 72-year-old man at the 25th percentile. The MESA CAC calculator (available from the MESA-NHLBI website) provides these percentiles [6].

Who Should Get the Test (and Who Should Skip It)

Not every menopausal woman needs a CAC scan. The test adds the most value when the treatment decision is genuinely uncertain.

Ideal Candidates

The 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease gives CAC scoring a Class IIa recommendation (reasonable to perform) for adults aged 40 to 75 with a 10-year ASCVD risk of 5% to 20% when the statin decision is unclear [3]. This borderline-to-intermediate zone captures a large share of recently postmenopausal women.

Specific scenarios where a CAC scan is most useful for menopausal women:

• Borderline calculated risk (5% to 7.5%) with a family history of premature coronary disease
• Early menopause (before age 45) or surgical menopause
• Considering hormone replacement therapy (HRT) and wanting a baseline assessment of coronary plaque
• Statin-hesitant patients who want objective data before committing to lifelong medication
• Metabolic syndrome features (elevated waist circumference, triglycerides, fasting glucose) not fully captured by the Pooled Cohort Equations

When to Skip It

Women already on a statin for established high risk or known atherosclerotic cardiovascular disease do not benefit from a screening CAC. The test also adds little for very low-risk women (10-year ASCVD risk <5%) or for women over 75 where statin benefit is established independent of calcium scores.

The 2018 AACE/ACE guideline on management of dyslipidemia also endorses CAC as a risk refinement tool, noting that "a CAC score of zero may be used to withhold statin therapy in appropriately selected patients" [7].

CAC Scoring and Hormone Replacement Therapy

The relationship between HRT and coronary calcium is one of the most studied intersections in menopause cardiology. The Women's Health Initiative (WHI) CAC sub-study (N=1,064) found that women randomized to conjugated equine estrogens (CEE) alone had significantly lower CAC scores after 7 years compared to placebo (83.1 vs. 123.1, P = 0.02) [8].

Timing Matters

This finding aligned with the "timing hypothesis," which posits that estrogen therapy initiated close to menopause onset (within 6 to 10 years) may slow early plaque formation, while initiation decades later provides no coronary benefit and may increase risk. The ELITE trial (N=643) confirmed that early-initiation estradiol slowed carotid intima-media thickness progression compared to placebo, but late-initiation estradiol did not [9].

Practical Use of CAC Before Starting HRT

A baseline CAC scan before initiating HRT can serve two purposes. First, a score of 0 or low (<100) in a symptomatic menopausal woman provides reassurance that coronary atherosclerosis has not yet established, supporting the safety profile of starting HRT within the timing window. Second, a high score (400+) may prompt a conversation about whether the cardiovascular risk profile warrants more caution with systemic estrogen, or at minimum, close lipid and blood pressure monitoring.

The 2022 Menopause Society position statement notes that for women aged 50 to 60 or within 10 years of menopause onset, the benefit-risk ratio of HRT is generally favorable for vasomotor symptoms, and cardiovascular risk assessment including CAC can help individualize the decision [10].

Interpreting Your Results: What Happens Next

A CAC score is not a diagnosis. It is a risk stratification tool that informs the next clinical conversation.

Score of 0

A zero score in a postmenopausal woman means the short-term probability of a coronary event is very low. In the MESA cohort, women with CAC = 0 had a 10-year CHD event rate of 1.4% [5]. This result can reasonably justify deferring statin therapy, intensifying lifestyle measures (Mediterranean diet, 150+ minutes of moderate exercise weekly, smoking cessation), and rechecking risk factors in 5 years.

Score of 1 to 99

Plaque is present. The conversation shifts. For a woman in this range who is at borderline calculated risk, the ACC/AHA guidelines favor statin initiation, particularly if the score places her above the 75th percentile for age and sex [3]. Lifestyle optimization is no longer optional. It becomes the foundation on which pharmacotherapy is added.

Score of 100 or Higher

"A CAC score greater than or equal to 100 Agatston units, or greater than or equal to the 75th percentile for age, sex, and ethnicity, favors statin therapy," states the 2019 ACC/AHA prevention guideline [3]. At this level, treatment intensity should match secondary-prevention targets in many cases. High-intensity statin therapy (atorvastatin 40 to 80 mg or rosuvastatin 20 to 40 mg), blood pressure control below 130/80 mmHg, and aggressive lifestyle changes are appropriate.

Does the Score Change Over Time?

CAC scores almost always increase over time because calcified plaque does not regress with current therapies. Statin treatment may paradoxically increase calcium density (by stabilizing soft plaque into calcified plaque), which is actually a favorable change despite raising the number [11]. For this reason, serial CAC scanning to "track progress" is not recommended. One baseline scan provides the risk information needed.

Practical Steps: Getting the Test Done

The logistics of CAC scoring are straightforward, but a few details matter.

Cost and Insurance

Most private insurers classify CAC screening as elective and do not cover it. Cash prices range from $75 at competitive imaging centers to $400 at academic medical centers. Some states (Texas, Illinois) have passed legislation encouraging or mandating insurance coverage for CAC screening in at-risk populations, but coverage remains inconsistent. Medicare does not cover screening CAC scans as of 2026.

Finding a Testing Center

Any facility with a multi-detector CT scanner can perform a CAC scan. Academic medical centers, freestanding imaging centers, and many hospital radiology departments offer the test. Ask specifically for a "coronary artery calcium score" or "cardiac calcium CT." No referral is needed in most states, but having a clinician order the test ensures results are interpreted in clinical context.

Radiation Exposure

The effective dose is approximately 1 mSv [12]. For comparison, a two-view screening mammogram delivers about 0.4 mSv, a chest CT delivers 7 mSv, and annual background radiation in the United States averages 3 mSv. The radiation from a single CAC scan is minimal and well within accepted limits for a screening test performed once.

Preparing for the Scan

No fasting required. No contrast dye. Avoid caffeine for 4 hours before the scan (caffeine can raise heart rate, reducing image quality). Wear comfortable clothing without metal snaps or underwire. The scan involves lying on the CT table for about 10 minutes total, with the actual image acquisition lasting a single breath-hold of 10 to 15 seconds.

What CAC Scoring Cannot Tell You

A CAC score has real limitations. It detects calcified plaque only, not soft (non-calcified) plaque, which can also rupture and cause heart attacks. Younger premenopausal or early perimenopausal women may have significant soft plaque with a CAC of 0. The scan does not assess coronary artery stenosis (narrowing); a CT angiogram (CCTA) is needed for that.

The test also cannot replace traditional risk factor management. A woman with a CAC of 0 who smokes, has uncontrolled hypertension, and eats a highly processed diet still carries meaningful cardiovascular risk from those modifiable factors. The zero score means calcified plaque has not yet formed. It does not guarantee future protection.